Personalized Genetic Medicine Infrastructure Support
GrantID: 67576
Grant Funding Amount Low: Open
Deadline: Ongoing
Grant Amount High: Open
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Individual grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Supporting Individuals with Rare Genetic Disorders
This grant funding is uniquely focused on personalizing genetic medicines tailored for individuals suffering from rare genetic disorders, prioritizing their specific needs in drug development. By directly collaborating with patient advocacy groups, the funding aims to address the unique challenges faced by these individuals, ensuring that their health and quality of life take center stage in therapeutic development. Unlike broader healthcare grants, this funding is specifically designed for the creation of tailored therapies and cannot be used for generalized medical services or conditions that do not fall under the rare disease category.
One application of these funds could involve a pilot program in which researchers develop individualized gene therapies for patients with conditions like Duchenne Muscular Dystrophy (DMD). This kind of initiative could lead not only to the development of effective treatments but also to better patient outcomes through personalized care strategies. Another potential project could involve the adaptation of existing therapies to suit the genomic makeup of patients affected by rare lysosomal storage disorders, effectively personalizing treatment based on patient genetic profiles.
Organizations eligible to apply for this funding include research institutions, biotechnology firms, and non-profits that demonstrate a commitment to advancing individual-based genetic therapies. Importantly, applicants must have a robust engagement with patient advocacy groups to ensure that the therapies developed are directly informed by patient experiences and needs. On the other hand, applications from entities focused on broad-spectrum medical treatments without an emphasis on rare genetic conditions will not qualify for consideration.
Successful alignment with the funding criteria necessitates a clear focus on patient-centered approaches and an evidence-based methodology for therapy development. Showcasing a historic understanding of patient needs and presenting effective patient engagement strategies will enhance the viability of an application. This funding not only supports the development of next-generation therapies but also champions the voices of those affected by rare genetic disorders.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grants for Public Events Supporting Culture and Inclusion
The grant transforms into a shared cultural space by funding creative events and community-led art p...
TGP Grant ID:
75465
Grants to Advance Artistic Development
Grants for artists are awarded to help underwrite actual project costs, not ordinary living expenses...
TGP Grant ID:
18242
Creative Community Grant Funding Opportunities for Local Projects
Small community-based funding opportunities support creative and experimental ideas across many loca...
TGP Grant ID:
6441
Grants for Public Events Supporting Culture and Inclusion
Deadline :
Ongoing
Funding Amount:
$0
The grant transforms into a shared cultural space by funding creative events and community-led art projects that are free and open to all. The program...
TGP Grant ID:
75465
Grants to Advance Artistic Development
Deadline :
2023-11-15
Funding Amount:
$0
Grants for artists are awarded to help underwrite actual project costs, not ordinary living expenses, and are intended to...
TGP Grant ID:
18242
Creative Community Grant Funding Opportunities for Local Projects
Deadline :
Ongoing
Funding Amount:
$0
Small community-based funding opportunities support creative and experimental ideas across many local regions in North America, Europe, Asia, and othe...
TGP Grant ID:
6441